The Swedish national guidelines on prostate cancer: recurrent, metastatic and castration resistant disease

Key Points

• To present the revised Swedish national guidelines for prostate cancer and explore their differences with European guidelines.
• Development of new recommendations for prostate cancer management based on current evidence.
• Comparison of Swedish guidelines with existing European guidelines.
• Multiple new recommendations addressing treatment for recurrent and metastatic disease were introduced.
• Significant differences from the European guidelines highlight unique approaches in Swedish prostate cancer management.